Skip to main content

Table 1 Patient characteristics

From: Comparison of the myocardial protective effect of sevoflurane versus propofol in patients undergoing heart valve replacement surgery with cardiopulmonary bypass

Patient characteristics

Propofol (n = 37)

Sevoflurane (n = 36)

Preoperative data

 Age (yr)

50.7 (6.6)

50.5 (6.4)

 Weight (kg)

54.5 (7.9)

56.5 (11.8)

 Sex (M/F)

18 / 19

16 / 20

 ASA class

II–IV

II–IV

 EF (%)

57.2 (5.6)

55.9 (5.4)

Types of surgery (n, %)

 Replacement of mitral valve

15 (40)

14 (39)

 Replacement of aortic valve

9 (24)

10 (28)

 Replacement of tricuspid valve

4 (10)

4 (11)

 Replacement of mitral valve and shaping of tricuspid valve

9 (24)

8 (22)

Intraoperative data

 Operating time (min)

198 (28)

183 (34)

 CPB time (min)

95 (18)

96 (17)

 Aortic clamp time (min)

62 (21)

64 (18)

 Ratio of automatic heart beat recovery (%)

62.2

83.3*

 Incidence of intraoperative awareness (%)

0

0

 Propofol (mg)

857.3 (166.5)

0

 Sevoflurane (MAC hour)

0

4.6 (0.9)

 Fentanyl (mg)

2.0 (0.2)

2.1 (0.3)

 Midazolam (mg)

20.6 (2. 9)

22.8 (3.0)

 Dopamine (mg)

57.3 (13.5)

45.9 (15.1)*

 Nitroglycerin (μg)

130.3 (50.2)

102.2 (34.5)*

 Epinephrine (μg)

148.7 (37.8)

111. 6 (19.6)*

Postoperative data

 Duration of mechanical ventilation time (hr)

9.4 (1.5)

6.2 (0.8)*

 Serious complications or death (%)

0

0

 ICU stay (hr)

48.6 (3.7)

42.3 (3.5)*

 Hospital stay (d)

16 (13–19)

12 (9–15)*

  1. Values are expressed as mean (SD) or median (range). *P < 0.05 vs the value of propofol group
  2. EF Ejection fraction, ASA class American Society of Anaesthesiologists physical status classification, MAC minimum alveolar concentration, MAC hr inhaled anaesthetic concentration/MAC × inhaled time (hr)